MUX Insider: Alfred Aguilar Colas Acquires 10,000 Options, Expires 2030
Rhea-AI Filing Summary
Alfred Aguilar Colas, identified as a director of McEwen Inc. (MUX), acquired 10,000 stock options on 08/11/2025 with an exercise price of $10.43. The options cover 10,000 shares of common stock, are reported as directly beneficially owned following the transaction, and have an expiration date of 08/11/2030.
The filing states the options vest in three equal annual installments beginning 08/11/2026. The transaction is reported as an acquisition (code "A") and the form indicates it was filed by one reporting person.
Positive
- Director grant disclosed: 10,000 stock options acquired by Alfred Aguilar Colas with an exercise price of $10.43.
- Clear vesting schedule: Options vest in three equal annual installments beginning 08/11/2026.
- Direct beneficial ownership: Reporting person is shown as directly owning 10,000 derivative securities following the transaction.
Negative
- None.
Insights
TL;DR: Director granted 10,000 options at $10.43, expiring 08/11/2030; vesting spreads over three years—routine compensation disclosure.
The Form 4 shows Alfred Aguilar Colas received 10,000 stock options on 08/11/2025 with an exercise price of $10.43 and an expiration of 08/11/2030. The options are reported as directly beneficially owned after the grant and are scheduled to vest in three equal annual installments beginning 08/11/2026. The transaction is coded as an acquisition and the filing was made by one reporting person. Based solely on the filing details, this appears to be a routine director option grant with no additional terms or cash consideration disclosed beyond the exercise price and vesting schedule.
TL;DR: Grant follows a multi-year vesting schedule; disclosure meets Section 16 reporting requirements for a director-level equity award.
The disclosure identifies the reporting person as a director and records a 10,000-option award with explicit vesting: three equal annual installments beginning 08/11/2026. The form records direct beneficial ownership of 10,000 derivative securities after the acquisition and lists the transaction code as "A" for acquisition. The option's exercise price ($10.43) and expiration (08/11/2030) are specified. The filing documents the award and the vesting timeline without additional contingencies or related-party arrangements disclosed in the form.